Journal
Oncotarget
Publication Date
10-8-2019
Volume
10
Issue
56
First Page
5824
Last Page
5834
Document Type
Open Access Publication
DOI
10.18632/oncotarget.27217
Rights and Permissions
Woodford MR, Hughes M, Sager RA, Backe SJ, Baker-Williams AJ, Bratslavsky MS, Jacob JM, Shapiro O, Wong M, Bratslavsky G, Bourboulia D, Mollapour M. Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity. Oncotarget. 2019 Oct 8;10(56):5824-5834. doi: 10.18632/oncotarget.27217. eCollection 2019 Oct 8. Copyright: Woodford et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Woodford, Mark R.; Hughes, Michael; Sager, Rebecca A.; Backe, Sarah J.; Baker-Williams, Alexander J.; Bratslavsky, Michael S.; Jacob, Joseph M.; Shapiro, Oleg; Wong, Michael; Bratslavsky, Gennady; Bourboulia, Dimitra; and Mollapour, Mehdi, "Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity." Oncotarget. 10, 56. 5824 - 5834. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8586
